1 / 5

The Flu Vaccines Market To Be Backed By Emphasis On Substantiation

Sustained investments will play an instrumental role in the development of tailor-made flu vaccines, according to a new Persistence Market Research (PMR) study. The market value crossed its US$ 4 Bn mark in 2018, says the report.

Télécharger la présentation

The Flu Vaccines Market To Be Backed By Emphasis On Substantiation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Flu Vaccines Market Report Id : PMRREP28720 Category : Life Science & Healthcare ©2020 Persistence Market Research, All Rights Reserved

  2. About Persistence Market Research Customized Research Persistence Market Research(Persistence Market Research) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. Persistence Market Research is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Syndicated Research Investment Research Social Media Research Research Capabilities Sector Coverage • Automotive and Transportation • Electronics, Semiconductor, and ICT • Retail and Consumer Products • Industrial Automation and Equipment • Customized Research • Syndicated Research • Investment Research • Social Media Research • Chemicals & Materials • Food and Beverages • Services and Utilities • Energy, Mining, Oil, and Gas Subscription Information For detailed subscription information please contact Website: www.persistencemarketresearch.com For sales queries or new topics email us on: sales@persistencemarketresearch.com

  3. The Flu Vaccines Market To Be Backed By Emphasis On Substantiation The influenza season is one of the key drivers that is triggering the demand for flu vaccines. Moreover, the surging number of COVID-19 patients has created an unprecedented demand for flu vaccines that prevent exposure to the novel virus. Sustained investments will play an instrumental role in the development of tailor-made flu vaccines, according to a new Persistence Market Research (PMR) study. The market value crossed its US$ 4 Bn mark in 2018, says the report. Modernization of manufacturing processes is vital to scale up the production of vaccines and meet growing demands of individuals, owing to the onset of the nearly approaching influenza pandemic. Manufacturers tap opportunities in oral approach to meet convenience of individuals. Universal vaccines emerge as cost efficient solutions for pharmaceutical companies. Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/28720

  4. Key Takeaways of Flu Vaccines Market Study • The flu vaccines market is slated to progress at a robust CAGR throughout the forecast period of 2020 – 2030, as companies focus on augmenting their investments in R&D activities in new manufacturing technologies. • Companies tap incremental opportunities in U.S., owing to high mortality rates caused by influenza. • Emergence of new strains has forced companies to introduce new updates in flu vaccines every year. • Strategic collaborations spark innovations in oral flu vaccines. • Antigens in universal flu vaccines hold promising potentials for fighting off new virus strains. • Oral flu vaccines in the form of pills to create high lucrative opportunities for companies. • “Emergence of new virus strains and opportunities in manufacturing technologies woul fuel growth for the flu vaccines market. Partnerships play a key role in developing easy-to-consume vaccines,” says a PMR analyst. Access Full Report @ https://www.persistencemarketresearch.com/checkout/28720

More Related